TOP TIERMARKET NEWSWIRE
News & sentiment

ACADIA PHARMACEUTICA (ACAD) — News & AI sentiment

ACADIA PHARMACEUTICA (ACAD) news roundup. 1 story in the past week, 11 over 30 days. Average 30-day sentiment is 56.6/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $412K — net selling of $412K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 66/100
30d stories
11
avg sentiment 56.6/100
Insider net (90d)
$412K
0 buys · 2 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on ACAD

3d ago
Stifel raises Acadia Pharmaceuticals price target on drug potential
Investing.com Analyst Ratings61 · neutralanalyst
Jul 20
Mizuho reiterates Acadia stock rating on Alzheimer’s trial progress
Investing.com Analyst Ratings56 · neutralanalyst
Jul 20
Jul 20
Jul 20
Jul 20
Jul 17
Jul 11
Jul 11
Jul 7
Jul 6
Jun 29
Jun 26
Why Acadia Pharmaceuticals Stock Is Soaring Today
The Motley Fool73 · bullishproduct/pr
Jun 26
Acadia rises as EU backs Rett syndrome therapy
Seeking Alpha73 · bullishproduct/pr
Jun 26
Jun 26
Jun 26
Jun 26
Acadia Pharmaceuticals: The Song Remains The Same
Seeking Alpha52 · neutralproduct/pr
Jun 22
Jun 12
ACADIA Pharmaceuticals Q1 Earnings Call Highlights
Yahoo Finance56 · neutralearnings
May 6
Acadia (ACAD) Q1 2026 Earnings Transcript
Yahoo Top50 · neutralearnings
May 6
Open ACAD in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →